journal article·2018-10-31Open access

Radiosensitivity enhancement of Fe 3 O 4 @Ag nanoparticles on human glioblastoma cells

Xiaohong Zhang, Zhujun Liu, Zhichao Lou, Feng Chen, Shuquan Chang, Yuji Miao, Zhuo Zhou, Xiaodan Hu, Jundong Feng, Qi Ding, Peidang Liu, Ning Gu, Haiqian Zhang

Abstract

Radiotherapy is one of the main therapeutic methods for cancers, but radiation resistance of cancer cells still remains a serious concern. Searching for radiosensitizers to overcome such resistance is therefore urgently required. The goal of this study is to evaluate and compare the radiosensitizing efficacy of Fe3O4-OA, Ag and Fe3O4@Ag nanoparticles on U251 cells. The results show that Fe3O4@Ag nanoparticles have the highest ability of radiosensitization among the three nanoparticles. The underlying mechanism of Fe3O4@Ag nanoparticles' radiosensitivity enhancement is through decrease of the cytoprotective autophagy at the early stage, and increase of the calcium-dependent apoptosis at the later stage. These findings suggest the potential application of Fe3O4@Ag nanoparticles as a highly effective nano-radiosensitizer for the treatment of glioblastoma cells.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Radiation Therapy and Dosimetry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nuclear Science and Engineering, Nanjing University of Aeronautics and Astronautics

Jiangsu Key Laboratory for Biomaterials and Devices, Southeast University

Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou University

College of Materials Science and Engineering, Nanjing Forestry University

Funding

National Natural Science Foundation of China

References (34)

Show source-provided references
1. Kwatra D, Venugopal A, Anant S. Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer. Transl Cancer Res. 2013;2:330–342.
2. 10.1177/10732748080150020710.1177/107327480801500207 ↗
3. Bergs Judith WJ, Wacker MG, Hehlgans S, et al. The role of recent nanotechnology in enhancing the efficacy of radiation therapy. Biochim Biophys Acta. 2015;1856:130–134.
4. 10.1016/j.biomaterials.2014.06.01010.1016/j.biomaterials.2014.06.010 ↗
5. 10.1039/c2nr31227a10.1039/c2nr31227a ↗
6. 10.1667/RR1984.110.1667/RR1984.1 ↗
7. 10.1039/c1nr10586h10.1039/c1nr10586h ↗
8. 10.1038/cr.2009.8910.1038/cr.2009.89 ↗
9. 10.1039/c3nr01351k10.1039/c3nr01351k ↗
10. 10.1016/j.biomaterials.2016.05.03110.1016/j.biomaterials.2016.05.031 ↗
11. 10.1016/j.biomaterials.2015.05.03310.1016/j.biomaterials.2015.05.033 ↗
12. 10.2147/IJN.S11547310.2147/IJN.S115473 ↗
13. Khiabani SS, Farshbaf M, Akbarzadeh A, et al. Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artif Cells Nanomed Biotechnol. 2016;1167704:6–17.
14. 10.1016/j.bbrc.2012.07.10810.1016/j.bbrc.2012.07.108 ↗
15. 10.7150/thno.541110.7150/thno.5411 ↗
16. Dizaji AN, Yilmaz M, Piskin E. Silver or gold deposition onto magnetite nanoparitcles by using plant extracts as reducing and stabilizing agents. Artif Cells Nanomed Biotechnol. 2015;1019672:1109–1115.
17. 10.1002/adma.20100026010.1002/adma.201000260 ↗
18. 10.1016/j.biomaterials.2017.01.04310.1016/j.biomaterials.2017.01.043 ↗
19. 10.1667/RR13774.110.1667/RR13774.1 ↗
20. 10.1007/s13277-010-0042-810.1007/s13277-010-0042-8 ↗
21. 10.1016/j.cellsig.2013.11.02810.1016/j.cellsig.2013.11.028 ↗
22. 10.1007/s11051-010-9937-y10.1007/s11051-010-9937-y ↗
23. 10.1080/21691401.2017.134794110.1080/21691401.2017.1347941 ↗
24. 10.1186/1471-2407-14-1710.1186/1471-2407-14-17 ↗
25. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
26. 10.1016/j.molcel.2015.06.01110.1016/j.molcel.2015.06.011 ↗
27. 10.1016/j.ceca.2011.03.00310.1016/j.ceca.2011.03.003 ↗
28. 10.1093/abbs/gms05110.1093/abbs/gms051 ↗
29. Robinson BW, Im MM, Ljungman M, et al. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells. Cancer Res. 2003;63:6935–6941.
30. 10.1016/0360-3016(94)00654-410.1016/0360-3016(94)00654-4 ↗
31. 10.1016/j.bbrc.2011.09.04610.1016/j.bbrc.2011.09.046 ↗
32. 10.1016/B978-0-323-52733-0.00006-910.1016/B978-0-323-52733-0.00006-9 ↗
33. 10.1007/s11010-012-1294-y10.1007/s11010-012-1294-y ↗
34. 10.1038/cddis.2009.1610.1038/cddis.2009.16 ↗